Table 2.
Adverse Events
| Adverse Event | 0 | 1 | 2 | 3 | 4 | 5 | Total |
|---|---|---|---|---|---|---|---|
| Leukopenia | 12 | 5 | 9 | 1 | 0 | 0 | 27 |
| Thrombocytopenia | 14 | 5 | 4 | 2 | 2 | 0 | 27 |
| Neutropenia | 13 | 2 | 6 | 4 | 2 | 0 | 27 |
| Anemia | 6 | 10 | 9 | 2 | 0 | 0 | 27 |
| Other Hematologic | 26 | 1 | 0 | 0 | 0 | 0 | 27 |
| Allergy/Immunology | 23 | 0 | 2 | 1 | 1 | 0 | 27 |
| Auditory/Ear | 26 | 0 | 1 | 0 | 0 | 0 | 27 |
| Cardiac | 26 | 1 | 0 | 0 | 0 | 0 | 27 |
| Coagulation | 25 | 1 | 1 | 0 | 0 | 0 | 27 |
| Constitutional | 10 | 10 | 6 | 1 | 0 | 0 | 27 |
| Dermatologic | 22 | 3 | 2 | 0 | 0 | 0 | 27 |
| Endocrine | 26 | 1 | 0 | 0 | 0 | 0 | 27 |
| Nausea | 6 | 14 | 5 | 2 | 0 | 0 | 27 |
| Vomiting | 14 | 9 | 1 | 3 | 0 | 0 | 27 |
| Gastrointestinal | 10 | 8 | 7 | 2 | 0 | 0 | 27 |
| Genitourinary/Renal | 26 | 1 | 0 | 0 | 0 | 0 | 27 |
| Hemorrhage | 25 | 1 | 0 | 0 | 0 | 1 | 27 |
| Lymphatics | 26 | 1 | 0 | 0 | 0 | 0 | 27 |
| Metabolic | 17 | 7 | 1 | 2 | 0 | 0 | 27 |
| Musculoskeletal | 25 | 2 | 0 | 0 | 0 | 0 | 27 |
| Neurosensory | 21 | 5 | 1 | 0 | 0 | 0 | 27 |
| Other Neurological | 22 | 3 | 2 | 0 | 0 | 0 | 27 |
| Ocular/Visual | 26 | 1 | 0 | 0 | 0 | 0 | 27 |
| Pain | 15 | 8 | 4 | 0 | 0 | 0 | 27 |
| Pulmonary | 21 | 6 | 0 | 0 | 0 | 0 | 27 |
| Vascular | 25 | 0 | 2 | 0 | 0 | 0 | 27 |